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Purpose: As endovascular therapy (EVT) has been approved as a treatment guideline for 
acute ischemic stroke (AIS), it has been increasing in Korea. We conducted a nationwide survey 
to evaluate the current status of EVT for patients with AIS in Korea. 
Materials and Methods: An electronic survey was sent to a representative clinician at each 
hospital where EVT was available in Korea. A Google survey was used to distribute the ques-
tionnaires and receive responses from October 2017 to December 2017.
Results: Among 120 hospitals in our society, 76 participated in this survey. In 26% of the 
hospitals, more than 50 annual cases of EVT were performed, and 25–50 annual cases in 37%. 
Fifty-six hospitals (73.7%) achieved successful recanalization (thrombolysis in cerebral infarction 
≥2b) in more than 80% of patients. Computed tomography (CT) angiography was the most 
common imaging modality for AIS treatment, and magnetic resonance (MR) diffusion, MR-per-
fusion/diffusion, and perfusion CT were frequently used in order. Non-eligibility criteria for EVT 
included a National Institutes of Health Stroke Scale <4 (64.5%), the absence of MR perfusion/
diffusion mismatch (52.6%), and a low Alberta Stroke Program Early CT Score (42.1%). For ante-
rior circulation stroke, 60% of Korean hospitals adopted a wider time range of “8 hours” from 
symptom onset, while 70% of hospitals had a time limitation of 12–24 hours for posterior circu-
lation stroke. The most preferred EVT device was a stentriever (89.4%). In the failed cases due to 
underlying stenosis, 79% of Korean hospitals performed angioplasty or stenting for revascular-
ization.
Conclusion: This first nationwide survey showed that most Korean hospitals conducted EVT 
for AIS patients according to the present guideline in the era of mechanical thrombectomy by 
integrating the clinical experiences of many medical institutions and specialists. 
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INTRODUCTION
In Korea, ischemic or hemorrhagic 
strokes are the third leading cause of 
death and the most frequent cause of 
disability.1,2 Since approval of tissue plas-
minogen activator (tPA) as the sole drug 
for treating acute ischemic strokes (AIS), 
some studies using intra-arterial throm-
bolytic therapy have been conducted 
but have failed to prove their efficacy.3-6 
With the advance of technologies and 
devices, several randomized controlled 
trials of endovascular treatment (EVT) for 
AIS have been conducted with success-
ful results since 2015.7-12 Based on these 
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results, EVT for AIS patients has been recommended strongly 
as level of evidence A13 and the Korean treatment guidelines 
for AIS were also revised in 2016.14
Since the introduction of neurointerventional procedures 
in 1994, neuroradiologists were initially involved with AIS 
treatment in Korea. During the past 4 years, the number of 
AIS patients treated with EVT has grown annually by an av-
erage of 36%, and the specialized institutions for treatment 
of AIS and the number of specialists, including neuroradiol-
ogists, neurosurgeons, and neurologists, have also increased 
rapidly in Korea.15 With this nationwide survey, we tried to 
evaluate the present status of hospitals and clinicians related 
to AIS treatment in Korea, focusing on preoperative imaging 
diagnosis, patient selection, endovascular methods, and fol-
low-up imaging.
MATERIALS AND METHODS
An electronic survey was sent to a representative clinician at 
each hospital where EVT was available in South Korea. The 
survey questionnaire was written in Korean and consisted of 
40 single- or multiple-choice questions about general infor-
mation of each hospital, preprocedural imaging evaluation, 
patient selection criteria, endovascular procedures, and fol-
low-up imaging (Supplementary material). A Google Survey 
was used to distribute the survey questionnaires and receive 
responses. This survey was carried out from October to De-
cember 2017. 
Questionnaire answers were evaluated with standard 
descriptive statistics (Microsoft Excel, Redmond, WA, USA). 
SPSS ver. 20.0 (SPSS Inc., Chicago, IL, USA) was used for sta-
tistical analysis. To examine the difference in the number of 
responses, chi-square was used for categorical variables.
RESULTS
Among 120 hospitals registered in our society, 76 partici-
pated in this survey, including 39 tertiary hospitals and 37 
non-tertiary hospitals (primary and secondary hospitals).  
General information 
In 26% of these hospitals (20/76), more than 50 annual cases 
of mechanical thrombectomy (MT) were performed, and 
25–50 annual cases in 37% (28/76). The number of tertiary 
hospitals that had performed more than 50 mechanical 
thrombectomies (MT) was 41% (16/39), whereas only 11% 
(4/37) of the non-tertiary hospitals had performed more 
than 50 MTs (P<0.001) (Fig. 1). In 2016, 93% of hospitals (71/76) 
achieved successful recanalization (thrombolysis in cerebral 
infarction [TICI] 2b/3) with MT in more than 70% of AIS pa-
tients; 22% (17/76) of hospitals had recanalized successfully 
more than 90% of patients and 51% (39/76) of hospitals had 
done so in 80-90% of patients (Fig. 2). 
In participating hospitals, the distribution of clinical spe-
cialty for clinicians involved in the neurointerventional 
procedures was neurosurgery (54%), radiology (30%), and 
neurology (16%). More than two clinicians managed patients 
with AIS in 82% of the procedures, and 91% of the hospitals 
ran at all hours with on-call night duty. The proportion of in-
volvement of three or more staff in EVT was 58.8% in tertiary 
hospitals and 29.7% in non-tertiary hospitals (P=0.012).
Thirty-eight percent (29/76) of the hospitals had a fellow-
ship training program for EVT, in which neurosurgeons (49%), 
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Fig. 1. Number of mechanical thrombectomy procedures per hospital 
in 2016 between tertiary and non-tertiary hospitals.
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Fig. 2. Successful recanalization rate after mechanical thrombectomy 
at the responding hospitals.
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neurologists (28%), and radiologists (23%) were enrolled. 
Especially, the fellowship program existed in 24 tertiary hos-
pitals. There was an inter-department consultation system in 
93% of the responding hospitals.
Specialized stroke units operated in 82% of hospitals. More 
than 90% of hospitals ran biplane digital subtraction angiog-
raphy, computed tomography (CT) and magnetic resonance 
imaging (MRI). 
Imaging modalities and patient selection 
CT angiography (CTA) was the most common imaging mo-
dality (32%) for AIS treatment, and MR-diffusion weighted 
imaging (DWI, 18%), MR-perfusion weighted imaging (PWI/
DWI, 18%), and perfusion CT (13%) were frequently used in 
that order. In case of unknown stroke onset, CTA (60%) was 
the first imaging option and MR-DWI (37%), non-contrast CT 
(32%), and MR-DWI/PWI (26%) were chosen sequentially for 
diagnosis. 
For anterior circulation stroke, 59% of respondents could 
perform EVT until 8 hours from onset of symptoms, and 25% 
did within 6 hours (Fig. 3). EVT could be treated until 12 hours 
from symptom onset in 10.5% of hospitals. For posterior cir-
culation stroke, EVT could be performed within 8 hours from 
onset in 27.6%, 12 hours in 36.8%, and 24 hours in 31.6% of 
hospitals, respectively. In order to determine EVT for posteri-
or circulation stroke, MR-DWI/PWI (12%), CTA (10%) and MR-
DWI (7%) were frequently used in that order. 
For the question regarding the non-eligibility for EVT, low 
National Institutes of Health Stroke Scale (NIHSS; <4), no DWI-
PWI mismatch, anatomical locations, and low Alberta Stroke 
Program Early CT Score (ASPECTS) were listed in that order 
(Table 1). For patients who were 90 years of age or older, 
there were some differences for treatment decisions ac-
cording to the responding hospitals, for which only 15.4% of 
the tertiary hospitals did not perform MT for them; whereas 
48.6% of the non-tertiary hospitals reported not performing 
MT. Furthermore, 10.3% of tertiary and 5.4% of non-tertiary 
hospitals responded that they could treat patients under any 
circumstances. 
In patients with mild stroke symptoms (NIHSS <4), non-ter-
tiary hospitals tended to treat more aggressively than tertiary 
hospitals; while only 15% of the latter treated distal middle 
cerebral artery (MCA) or anterior cerebral artery (ACA) oc-
clusion, 32% of the former would perform EVT for the same 
occlusion (P<0.002). However, there was a similar response 
between tertiary and non-tertiary hospitals in case of basilar 
artery occlusion.
Anesthetic consideration
During EVT for AIS patients, conscious sedation was per-
formed frequently in 56% (41/73) of hospitals, local anesthe-
sia in 33% (24/73), and general anesthesia was occasionally 
performed in 11% (8/73, 3 in tertiary and 5 in non-tertiary 
hospitals). 
Endovascular treatment procedure 
In total, 80% of the hospitals performed intravenous tPA 
followed by MT immediately, and the amount of tPA used 
was a full dose (0.9 mg/kg) in 78%. For MT, a stentriever was 
frequently selected as the preferred device in 89% and an 
aspiration device in 11% of procedures. As a first-line device, 
Solitaire was chosen in 68%, Trevo in 18%, Penumbra in 12%, 
and ERIC in 1%. For the second-line option, Penumbra was 
the highest in 42%, Trevo in 28%, Solitaire in 25%, ERIC in 4%, 
and Revive SE in 1% (Table 2). The number of passes by a 
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Fig. 3. Time range after symptom onset for AIS treatment between 
anterior and posterior circulation. AIS, acute ischemic stroke.
Table 1. Selection criteria for patients not having mechanical 
thrombectomy
Variable Tertiary Non-tertiary
NIHSS <4 25 (64.1) 24 (64.9)
Old age (>90) 6 (15.4) 18 (48.6)
Anatomical location 13 (33.3) 19 (51.4)
Low ASPECTS 18 (46.2) 14 (37.8)
No DWI-PWI mismatch 20 (51.3) 20 (54.1)
None of the above 4 (10.3) 2 (5.4)
Values are presented as number of response (%).
NIHSS, National Institutes of Health Stroke Scale; ASPECTS, Alberta 
Stroke Program Early CT Score; DWI, diffusion weighted imaging; 
PWI, perfusion weighted imaging.
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stentriever was 3 to 5 in 64% and more than 5 in 36%.
The proportion of hospitals that used balloon-guiding 
catheters for more than 60% of their procedures was 42%, 
and 18% of hospitals never used balloon-guiding catheters 
(BGC). The proportion of hospitals that used intermediate 
catheters for more than 60% of procedures was 42%, and 
16% of hospitals did not use intermediate catheters. 63% of 
hospitals could use both catheters together in EVT for AIS 
patients.
In the case of tandem occlusion, revascularization of the 
proximal lesion first followed by distal recanalization was pre-
ferred in 70% of hospitals. When intracranial artery occlusion 
with underlying stenosis occurred, angioplasty and stenting 
was performed in 51% of hospitals and only angioplasty in 
28%. Only intra-arterial or intravenous injection of tirofiban 
was administered in 18% of hospitals and bypass surgery 
was in 3%. Finally, 61% of hospitals answered that intraarterial 
injection of urokinase or tirofiban was used in <10% of pro-
cedures.
Follow-up imaging
In 69.7% of hospitals, follow-up imaging was taken within 
24–48 hours after the procedure (Table 3). The proportion at 
which the follow-up imaging study was performed imme-
diately or 7 days after EVT was 12% and 13%, respectively. In 
order to confirm the final infarction volume, the preferred 
imaging study was either only MRI (49%) or CT plus MRI (42%).
DISCUSSION
After reporting Korean neurointerventional activities in 
2013,16 this study is the initial investigation into the current 
status of EVT in the era of MT for AIS. We found most Korean 
hospitals had an excellent environment for AIS patients. They 
have a lot of medical equipment, ranking fifth in the number 
of MRIs and sixth in the number of CTs among developed 
countries, and have high medical accessibility due to the Na-
tional Medical Insurance scheme for all citizens.17 Regarding 
the human resource for AIS treatment, radiologists, neuro-
surgeons, and neurologists have been responsible for AIS 
treatment in most Korean hospitals. Recently, 62% of tertiary 
hospitals have operated a fellowship program for training 
specialized experts.
According to the hospitals, there was a significant differ-
ence in the number of cerebral angiography and AIS pa-
tients who underwent MT, which may be explained by the 
following facts: 1) Among 43 tertiary hospitals, 11 hospitals 
were designated as Regional Cardio-Cerebrovascular Disease 
Centers by the government as well as large-scale emergen-
cy centers, where a large portion of AIS patients may be 
transferred by an ambulance; and 2) Most Korean hospitals 
are open at all hours for on-call AIS management, as found 
in this survey. However, non-tertiary hospitals had some dif-
ficulties managing AIS patients on-call at all hours due to a 
lack of medical staff and specialists who could perform MT.
In the guidelines,18 treatment for AIS patients using MT 
can be initiated within 6 hours after the onset of symptoms 
and in selected patients with AIS within 6 to 24 hours who 
have large vessel occlusion in the anterior circulation. In this 
study, it is interesting that 60% of Korean hospitals adopted 
the wider time range of “8 hours” from symptom onset for 
anterior circulation stroke, and 70% of hospitals tried to treat 
posterior circulation stroke within 12–24 hours from onset. 
CTA was primarily applied for preoperative diagnosis and 
treatment decision of AIS patients at most of Korean hospi-
tals, while MRI was the first imaging tool used for posterior 
Table 3. Follow-up imaging modality and time
Value
Imaging modality
CT and MRI 32 (42.1)
MRI 37 (48.0)
CT 7 (9.2)
Time
Immediately 9 (11.8)
24–48 hours 53 (69.7)
1 week 10 (13.2)
Before discharge 4 (5.3)
Values are presented as number (%).
CT, computed tomography; MRI, magnetic resonance imaging.
Table 2. Devices preferred for mechanical thrombectomy
Tertiary Non-tertiary
1st line 2nd line 1st line 2nd line
Solitaire 25 10 27 9
Trevo 6 10 8 11
ERIC 1 1 0 2
Revive 0 0 0 1
Penumbra 7 18 2 14
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circulation stroke. 
The current guidelines18 show that patients should receive 
MT with a stent retriever if they meet all the following criteria: 
1) a prestroke modified Rankin Score (mRS) of 0 to 1; 2) caus-
ative occlusion of the internal carotid artery or MCA segment 
1 (M1); 3) age ≥18 years; 4) NIHSS score of ≥6; 5) ASPECTS 
of ≥6; and 6) treatment initiated (groin puncture) within 6 
hours of symptom onset. In this survey, some Korean hospi-
tals adapted aggressive criteria for AIS treatment, including 
a low NIHSS (<4), low ASPECTS (<5) and distal MCA or ACA 
occlusion, which may be considered for treatment as class IIb 
recommendation in some circumstances. 
In Korea, the stentriever was the most preferred treatment 
device, while an aspiration device was chosen as a second 
option. Although a BGC or intermediate catheter was used 
frequently in AIS procedures, a BGC was not used yet in 18% 
of Korean hospitals. In a recent publication,19 a BGC has been 
known to not only have a high success rate of recanalization 
but also reduce the occurrence of distal emboli and opera-
tion time, and it is expected that use of a BGC will increase 
further. 
For failed cases due to underlying stenosis, there is a trend 
to perform aggressive treatments in Korea, including angio-
plasty or stenting. Intracranial atherosclerotic stenosis (ICAS) 
is one of the main causes of ischemic stroke, especially in 
East Asia.20 The major stroke mechanism related to the ICAS 
is in situ thrombo-occlusion.21 When patients with ICAS are 
treated using MT, endothelial damage may occur, causing 
immediate reocclusion and failure of recanalization.22 In re-
cent reports, tirofiban, a glycoprotein IIb/IIIa inhibitor, had a 
positive effect as an alternative in the reocclusive cases,22,23 
and angioplasty and stenting or only angioplasty have been 
the last resort in these failed cases.24,25
The present study has some limitations. Since the study is 
based only on survey responses, it is possible to infer a recent 
trend for AIS treatment rather than providing exact clinical 
data. 
CONCLUSION
This study demonstrates that most Korean hospitals con-
ducted EVT for AIS patients according to the present guide-
line, which provides insight into the current status of AIS 
treatment according to this first nationwide survey in the 
era of MT. As the demand for AIS treatment increases, the 
academic society should prepare to cope actively with ex-
pected problems, such as education and quality control for 
involved hospitals and specialists and prepare for the estab-
lishment of a new guideline.    
SUppLEMENTARy MATERIALS
Supplementary materials related to this article can be found 
online at https://doi.org/10.5469/neuroint.2018.01053.
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